Vaccine Buyers Get Sanofi's Antitrust Claim Scrapped
By Keith Goldberg (December 21, 2012, 5:43 PM EST) -- The New Jersey federal judge overseeing a proposed class action claiming Sanofi Pasteur Inc. pushed anti-competitive contract restrictions onto vaccine customers tossed the drugmaker's antitrust counterclaim on Thursday, saying Sanofi hadn't supported assertions that customers colluded to demand discounts that lowered vaccine prices to noncompetitive levels.
In granting the medical practitioner plaintiffs' motion to dismiss the counterclaim, U.S. District Judge Jose L. Linares said Sanofi hadn't alleged facts to support the plausible inference that the physician buying groups that entered agreements with the drugmaker to buy vaccines either fixed prices or restricted purchases.
The judge also said Sanofi hadn't adequately alleged...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!